New interview in BioStock: How Enzymatica is stepping up internationally

What does the next phase look like for Enzymatica – and what role does the strategic partnership with STADA Arzneimittel AG play?

In a new interview with BioStock, our CEO Sana Alajmovic shares her perspectives on the Q1 results, the company’s development, and how the collaboration with STADA is accelerating our international expansion.

Read the full interview here: BioStock-How Enzymatica is stepping up internationally